Recruitment for Oxford Covid-19 trial of Trump-backed hydroxychloroquine is HALTED

The UK's drugs watchdog has asked Oxford University researchers to pull the plug on the antimalarial amid concerns it might raise the risk of heart attacks in very unwell Covid patients.